Patent Information
- Patent Title: PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME
- Granting Authority: European Patent Office
- Grant Date: July 15, 2026 (as per certificate date)
- Disclosure Date: August 11, 2026
Technical Description
The invention relates to a pharmaceutical composition comprising novel anti-cancer compounds in combination with a solubilising agent. The composition is designed to enhance the solubility and bioavailability of the active compounds, thereby improving their therapeutic potential. The disclosure includes the process to prepare this composition.
Therapeutic Applications
The composition has significant applications in the treatment of various cancers, including:
- Breast cancer
- Prostate cancer
The invention is particularly focused on oral administration methods.
Strategic Impact
The patent grant strengthens the Company's oncology-focused intellectual property portfolio and covers the use of the pharmaceutical composition for the treatment and management of various cancers.